Ultrastructural and Molecular Evidence of Macroautophagy in Functioning PitNETs and Experimental Pituitary Tumors

Introduction: Macroautophagy is a lysosome-mediated degradation process that controls the quality of cytoplasmic components and organelles, with its regulation depending on autophagy-related proteins (Atg) and with Beclin1/Atg6 and microtubule-associated protein light chain 3 (LC3/Atg8) being key players in the mammalian autophagy. As reports on this mechanism in the field of pituitary neuropathology and neuroendocrinology are scarce, our study analyzed the ultrastructural signs of macroautophagy and the expression of Beclin1 and LC3 proteins in human functioning PitNETs and in experimental pituitary tumors. Methods: A group of humans functioning PitNETs and an experimental lactotroph model in rats of the F344 strain stimulated with estradiol benzoate (BE) were used. Ultrastructural and molecular evidence of the macroautophagic process was evaluated using different techniques. Results: In functioning PitNETs cohort, 60% exhibited evidence of macroautophagy, with a significant difference found for Beclin1 and LC3 between macro- and micro-PitNETs (p < 0.05). In the experimental model, the expression of both Beclin1 and LC3 proteins was immunopositive in normal and tumoral glands when analyzed by immunofluorescence, Western blot, and immunohistochemistry. In the experimental model, protein expression was associated with increased glandular size and weight. Conclusions: Our study revealed evidence of macroautophagy at the pituitary level and the important role of Beclin1 and LC3 in the progression of functioning PitNETs, implying that this mechanism participate in regulating pituitary cell growth.

[1]  A. D. De Paul,et al.  Architects of Pituitary Tumour Growth , 2022, Frontiers in Endocrinology.

[2]  Zhoubin Tan,et al.  Celastrol Induces Apoptosis and Autophagy via the AKT/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells , 2022, Current Medical Science.

[3]  B. Wenig,et al.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms , 2022, Head and Neck Pathology.

[4]  D. Rubinsztein,et al.  The different autophagy degradation pathways and neurodegeneration , 2022, Neuron.

[5]  D. Koya,et al.  Autophagy in metabolic disease and ageing , 2021, Nature Reviews Endocrinology.

[6]  Sangam Rajak,et al.  MTORC1-dependent crinophagy regulates glucagon content in pancreatic α-cells , 2021, Autophagy.

[7]  G. Kroemer,et al.  Autophagy in metabolism and quality control: opposing, complementary or interlinked functions? , 2021, Autophagy.

[8]  Renlong Pan,et al.  Ki-67 labeling index and Knosp classification of pituitary adenomas , 2021, British journal of neurosurgery.

[9]  A. Giustina,et al.  Autophagy in normal pituitary and pituitary tumor cells and its potential role in the actions of somatostatin receptor ligands in acromegaly , 2021, Reviews in Endocrine and Metabolic Disorders.

[10]  Xiao-hai Liu,et al.  How to Classify and Define Pituitary Tumors: Recent Advances and Current Controversies , 2021, Frontiers in Endocrinology.

[11]  P. Chanson,et al.  Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time? , 2021, Journal of the Endocrine Society.

[12]  John G Doench,et al.  Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin , 2021, Proceedings of the National Academy of Sciences.

[13]  L. D. Sosa,et al.  Changes of stem cell niche during experimental pituitary tumor development , 2021, Journal of neuroendocrinology.

[14]  Jinbao Liu,et al.  Selective autophagy of intracellular organelles: recent research advances , 2021, Theranostics.

[15]  Sheng Tu,et al.  Selective autophagy as a therapeutic target for neurological diseases , 2020, Cellular and Molecular Life Sciences.

[16]  L. D. Sosa,et al.  Association of PTP4A3 expression and tumour size in functioning pituitary adenoma: a descriptive study , 2020, Journal of Clinical Pathology.

[17]  G. Juhász,et al.  Autophagosome-lysosome fusion. , 2020, Journal of molecular biology.

[18]  Dong Li,et al.  Role of the autophagy-related marker LC3 expression in hepatocellular carcinoma: a meta-analysis , 2020, Journal of Cancer Research and Clinical Oncology.

[19]  L. Brisson,et al.  Autophagy and mitophagy in cancer metabolic remodelling. , 2020, Seminars in cell & developmental biology.

[20]  A. Giustina,et al.  Effects of octreotide on autophagy markers and cell viability markers related to metabolic activity in rat pituitary tumor cells , 2020, Pituitary.

[21]  Na Li,et al.  Mitochondrial Dysfunction Pathway Networks and Mitochondrial Dynamics in the Pathogenesis of Pituitary Adenomas , 2019, Front. Endocrinol..

[22]  N. Barnich,et al.  New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD , 2019, Autophagy.

[23]  B. Bender,et al.  Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas , 2019, Acta Neurochirurgica.

[24]  Chao Tang,et al.  (A221) Bromocriptine and Cabergoline Induces Cell Death in Prolactinoma Cells via the ERK/EGR1 and AKT/MTOR Pathway Respectively , 2019, 29th Annual Meeting North American Skull Base Society.

[25]  S. Güllü,et al.  The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas , 2019, Endocrine Pathology.

[26]  A. Giatromanolaki,et al.  LC3A, LC3B and Beclin-1 Expression in Gastric Cancer , 2018, AntiCancer Research.

[27]  Hui Fang,et al.  Expression of autophagy-associated proteins in papillary thyroid carcinoma. , 2017, Oncology letters.

[28]  K. Macleod,et al.  Expanding perspectives on the significance of mitophagy in cancer. , 2017, Seminars in cancer biology.

[29]  Meng Li,et al.  Bromocriptine Induces Autophagy-Dependent Cell Death in Pituitary Adenomas. , 2017, World neurosurgery.

[30]  P. Chanson,et al.  From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. , 2017, Endocrine-related cancer.

[31]  L. Xiaoli,et al.  HIF-1α Inhibition Sensitized Pituitary Adenoma Cells to Temozolomide by Regulating Presenilin 1 Expression and Autophagy , 2016, Technology in cancer research & treatment.

[32]  H. Biceroglu,et al.  Preoperative Somatostatin Analogue Treatment Might Trigger Apoptosis and Autophagy in Tumor Tissues of Patients with Acromegaly: A Pilot Study. , 2016, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[33]  K. Otsu.  "Autophagy in the Heart". , 2016, Journal of molecular and cellular cardiology.

[34]  H. Iwata,et al.  Clinical significance of the expression of autophagy-associated marker, beclin 1, in breast cancer patients who received neoadjuvant endocrine therapy , 2016, BMC Cancer.

[35]  C. Finkielstein,et al.  Moderate Exercise Prevents Functional Remodeling of the Anterior Pituitary Gland in Diet-Induced Insulin Resistance in Rats: Role of Oxidative Stress and Autophagy. , 2016, Endocrinology.

[36]  H. Shang,et al.  Suppression of mTOR pathway and induction of autophagy-dependent cell death by cabergoline , 2015, Oncotarget.

[37]  S. Kyo,et al.  Loss of autophagy-related protein Beclin 1 may define poor prognosis in ovarian clear cell carcinomas , 2015, International journal of oncology.

[38]  L. D. Sosa,et al.  Evidence of cellular senescence during the development of estrogen-induced pituitary tumors. , 2015, Endocrine-related cancer.

[39]  N. Cho,et al.  Rapid Reticulin Fiber Staining Method is Helpful for the Diagnosis of Pituitary Adenoma in Frozen Section , 2015, Endocrine Pathology.

[40]  I. Soldatovic,et al.  Immunohistochemical Expression of p16 and p21 in Pituitary Tissue Adjacent to Pituitary Adenoma versus Pituitary Tissue Obtained at Autopsy: Is There a Difference? , 2015, Endocrine Pathology.

[41]  Haikuo Tang,et al.  Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines. , 2014, Oral oncology.

[42]  D. Klionsky.  Coming soon to a journal near you—The updated guidelines for the use and interpretation of assays for monitoring autophagy , 2014, Autophagy.

[43]  Zheng-sheng Wu,et al.  Clinical significance of autophagic protein LC3 levels and its correlation with XIAP expression in hepatocellular carcinoma , 2014, Medical Oncology.

[44]  Gang Chen,et al.  Increased expression of autophagy-related proteins in keratocystic odontogenic tumours: its possible association with growth potential. , 2014, The British journal of oral & maxillofacial surgery.

[45]  K. Kovacs,et al.  Autophagy in the endocrine glands. , 2014, Journal of molecular endocrinology.

[46]  F. Saggioro,et al.  Components of the Canonical and Non-Canonical Wnt Pathways Are Not Mis-Expressed in Pituitary Tumors , 2013, PloS one.

[47]  K. Mills,et al.  Autophagy and inflammatory diseases , 2013, Immunology and cell biology.

[48]  Ji-Eun Kim,et al.  Beclin1-induced autophagy abrogates radioresistance of lung cancer cells by suppressing osteopontin. , 2012, Journal of radiation research.

[49]  D. Klionsky,et al.  Eaten alive: a history of macroautophagy , 2010, Nature Cell Biology.

[50]  D. Massi,et al.  Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. , 2010, Human pathology.

[51]  G. Mills,et al.  Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3 , 2008, Autophagy.

[52]  N. Mizushima,et al.  How to Interpret LC3 Immunoblotting , 2007, Autophagy.

[53]  R. Lloyd,et al.  Type IV collagen immunostaining is a simple, reliable diagnostic tool for distinguishing between adenomatous and normal pituitary glands. , 2007, Archives of pathology & laboratory medicine.

[54]  S. Melmed,et al.  Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. , 2007, Endocrine reviews.

[55]  J. P. Petiti,et al.  Pattern of FGF-2 isoform expression correlated with its biological action in experimental prolactinomas , 2006, Acta Neuropathologica.

[56]  B. Levine,et al.  Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. , 2001, Cancer research.

[57]  T. Peters,et al.  Inappropriately low serum GH in an acromegalic: lysosomal involvement in intracellular hormone degradation. , 1982, Metabolism: clinical and experimental.

[58]  K. Kovacs,et al.  Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. , 1980, The American journal of pathology.

[59]  Huanbai Xu,et al.  Autophagy and Obesity and Diabetes. , 2020, Advances in experimental medicine and biology.

[60]  G. Juhász,et al.  Crinophagy mechanisms and its potential role in human health and disease. , 2020, Progress in molecular biology and translational science.

[61]  Jun Fan,et al.  Expression of glucose transporter-1, hypoxia inducible factor-1α and beclin-1 in head and neck cancer and their implication. , 2018, International journal of clinical and experimental pathology.

[62]  L. Galluzzi,et al.  Autophagy Mediates Tumor Suppression via Cellular Senescence. , 2016, Trends in cell biology.

[63]  P. Clave,et al.  Atypical pituitary adenomas: 10 years of experience in a reference centre in Portugal. , 2016, Neurologia.

[64]  Hong Shi,et al.  Beclin1 overexpression inhibitis proliferation, invasion and migration of CaSki cervical cancer cells. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[65]  M. Serrano,et al.  Senescence in tumours: evidence from mice and humans , 2010, Nature Reviews Cancer.

[66]  Y. Doki,et al.  LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. , 2008, International journal of oncology.